Ovarian reserve assessment for infertility investigation
- PMID: 22474591
- PMCID: PMC3302183
- DOI: 10.5402/2012/576385
Ovarian reserve assessment for infertility investigation
Abstract
The current trends to postpone motherhood and the increase in demand for assistance in reproductive medicine highlight the need for seeking guidelines for the establishment of individualized treatment protocols. Currently available ovarian reserve tests do not provide sufficient evidence to be solely considered ideal, but they may occupy important place in initial counseling, predicting unsatisfactory results that could be improved by individualized induction schemes and reducing excessive psychological and financial burdens, and adverse effects. In this paper, we revise the role of hormonal basal and dynamic tests, as well as ultrasonographic markers, as ovarian reserve markers, in order to provide embasement for propaedeutic strategies and their interpretation in order to have reproductive success.
References
-
- Leridon H. 30 years of contraception in France. Contraception Fertilite Sexualite. 1998;26(6):435–438. - PubMed
-
- Sharara FI, Scott RT., Jr. Assessment of ovarian reserve and treatment of low responders. Infertility and Reproductive Medicine Clinics of North America. 1997;8(4):501–522.
-
- Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocrine Reviews. 1996;17(2):121–155. - PubMed
-
- Tremellen KP, Kolo M, Gilmore A, Lekamge DN. Anti-müllerian hormone as a marker of ovarian reserve. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2005;45(1):20–24. - PubMed
-
- Fanchin R, Taieb J, Lozano DHM, Ducot B, Frydman R, Bouyer J. High reproducibility of serum anti-Müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Human Reproduction. 2005;20(4):923–927. - PubMed
LinkOut - more resources
Full Text Sources